MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α

International Journal of Cancer

Volumn 133, Issue 4, 2013, Pages 867-878

  Yeh, Yu Ming ^a,b   Chuang, Chi Mu ^c,d   Chao, Kuan Chong ^c   Wang, Lu Hai ^a,b  

^a National Health Research Institutes (NHRI)   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

HIF 1 ; invasion metastasis; microRNA; ovarian cancer; SOX4

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; MICRORNA 138; PROTEASOME; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SOX4; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER STAGING; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE MODEL; DOWN REGULATION; DRUG TARGETING; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS INHIBITION; MOUSE; NONHUMAN; OVARY CANCER; PERITONEUM METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; TRANSCRIPTION REGULATION; UPREGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SOXC TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84878830070     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28086     Document Type: Article

References (44)

1. Clarke-Pearson DL,. Clinical practice. Screening for ovarian cancer. N Engl J Med 2009; 361: 170-7.
2. Naora H, Montell DJ,. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 2005; 5: 355-66. (Pubitemid 40637827)
3. Wang L, Wang J,. MicroRNA-mediated breast cancer metastasis: from primary site to distant organs. Oncogene 2012; 31: 2499-511.
4. Cowden Dahl KD, Dahl R, Kruichak JN, et al. The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia 2009; 11: 1208-15.
5. Corney DC, Hwang CI, Matoso A, et al. Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res 2010; 16: 1119-28.
6. Liu X, Jiang L, Wang A, et al. MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 2009; 286: 217-22.
7. Yip L, Kelly L, Shuai Y, et al. MicroRNA signature distinguished the degree of aggressiveness of papillary thryoid carcinoma. Ann Surg Oncol 2011; 18: 7.
8. Seike M, Goto A, Okano T, et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci USA 2009; 106: 12085-90.
9. Jiang L, Liu X, Kolokythas A, et al. Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer 2010; 127: 8.
10. Cheng GZ, Chan J, Wang Q, et al. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 2007; 67: 1979-87. (Pubitemid 46424214)
11. Wang GL, Jiang BH, Rue EA, et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-4.
12. Zuo JH, Zhu W, Li MY, et al. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem 2011; 112: 2508-17.
13. Jin W, Chen BB, Li JY, et al. TIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway. Mol Cell Biol 2012; 32: 50-63.
14. Arora P, Cuevas BD, Russo A, et al. Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion. Oncogene 2008; 27: 4434-45.
15. Liao YL, Sun YM, Chau GY, et al. Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma. Oncogene 2008; 27: 5578-89.
16. Scharer CD, McCabe CD, Ali-Seyed M, et al. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res 2009; 69: 709-17.
17. Penzo-Mendez AI,. Critical roles for SoxC transcription factors in development and cancer. Int J Biochem Cell Biol 2010; 42: 425-8.
18. Huang CH, Yang WH, Chang SY, et al. Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis. Neoplasia 2009; 11: 1371-82.
19. Yang MH, Wu MZ, Chiou SH, et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 2008; 10: 295-305.
20. Imai T, Horiuchi A, Wang C, et al. Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol 2003; 163: 1437-47. (Pubitemid 37175091)
21. Elloul S, Elstrand MB, Nesland JM, et al. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 2005; 103: 1631-43. (Pubitemid 40490024)
22. Gallo D, Ferlini C, Scambia G,. The epithelial-mesenchymal transition and the estrogen-signaling in ovarian cancer. Curr Drug Targets 2010; 11: 474-81.
23. Lassus H, Sihto H, Leminen A, et al. Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma. J Mol Med (Berl) 2006; 84: 671-81. (Pubitemid 44164262)
24. Brustmann H,. Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome. Int J Gynecol Pathol 2008; 27: 380-9.
25. Mitomo S, Maesawa C, Ogasawara S, et al. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci 2008; 99: 280-6. (Pubitemid 351228481)
26. Zhao X, Yang L, Hu J, et al. miR-138 might reverse multidrug resistance of leukemia cells. Leuk Res 2010; 34: 1078-82.
27. Wang Q, Zhong M, Liu W, et al. Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP). Exp Lung Res 2011; 37: 427-34.
28. Griffiths-Jones S, Saini HK, van Dongen S, et al. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008; 36: D154-D158. (Pubitemid 351149713)
29. Messeguer X, Escudero R, Farre D, et al. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 2002; 18: 333-4. (Pubitemid 34183117)
30. Gross KL, Cidlowski JA,. Tissue-specific glucocorticoid action: a family affair. Trends Endocrinol Metab 2008; 19: 331-9.
31. Law ME, Corsino PE, Jahn SC, et al. Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms. Oncogene 2012, doi:10.1038/onc.2012.138.
32. Aaboe M, Birkenkamp-Demtroder K, Wiuf C, et al. SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res 2006; 66: 3434-42.
33. Gunes S, Yegin Z, Sullu Y, et al. SOX4 expression levels in urothelial bladder carcinoma. Pathol Res Pract 2011; 207: 423-7.
34. Medina PP, Castillo SD, Blanco S, et al. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer. Hum Mol Genet 2009; 18: 1343-52.
35. Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451: 147-52.
36. Sheng Q, Liu J,. The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer. Br J Cancer 2011; 104: 1241-5.
37. Siwak DR, Carey M, Hennessy BT, et al. Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges. J Oncol 2010; 2010: 568938.
38. Semenza GL,. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-32. (Pubitemid 37328811)
39. Jiang J, Tang YL, Liang XH,. EMT: a new vision of hypoxia promoting cancer progression. Cancer Biol Ther 2011; 11: 714-23.
40. Vernon AE, LaBonne C,. Slug stability is dynamically regulated during neural crest development by the F-box protein Ppa. Development 2006; 133: 3359-70. (Pubitemid 44501838)
41. Vinas-Castells R, Beltran M, Valls G, et al. The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation. J Biol Chem 2010; 285: 3794-805.
42. Lubec B, Labudova O, Hoeger H, et al. Expression of transcription factors in the brain of rats with perinatal asphyxia. Biol Neonate 2002; 81: 266-78. (Pubitemid 34507595)
43. Liu XS, Zhang ZG, Zhang RL, et al. Comparison of in vivo and in vitro gene expression profiles in subventricular zone neural progenitor cells from the adult mouse after middle cerebral artery occlusion. Neuroscience 2007; 146: 1053-61. (Pubitemid 46694148)
44. Lendahl U, Lee KL, Yang H, et al. Generating specificity and diversity in the transcriptional response to hypoxia. Nat Rev Genet 2009; 10: 821-32.